Tag: $5.29b
-
Pfizer, US ink $5.29B deal for possible COVID-19 treatment
[ad_1] This image provided by Pfizer shows its COVID-19 pills. Drugmaker Pfizer said Tuesday, Nov. 16, 2021, it is submitting its experimental pill for U.S. authorization, setting the stage for a likely launch in coming weeks. (Pfizer via AP) NEW YORK – The U.S. government will pay drugmaker Pfizer $5.29 billion for 10…